Recent Updates
Recently added Catalysts
BCRX Positive Sentiment

BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference

Tuesday, January 6, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: BioCryst Pharmaceuticals, Inc. has announced its participation at the 44th Annual J.P. Morgan Healthcare Conference, which is scheduled for January 12, 2026. The presentation will take place at 1:30 p.m. ET and will be available for live audio webcast. This event is significant for BioCryst as it represents an opportunity to engage with investors and share updates on its progress.
Price reaction · baseline $7.41 (2026-01-05 close) · hit after-hours · clean, no other BCRX news in the window
day 0 close · peak
+2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • BioCryst will showcase its latest developments at a major healthcare conference.
  • The participation in the J.P. Morgan Healthcare Conference highlights BioCryst's ongoing engagement with investors.
  • The live audio webcast allows for wide access to the presentation, promoting transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+23%
120-day peak, hindsight
Typical move
2.6%
average across 4 past catalysts
Lead asset
Peramivir
Phase 3 · Influenza

Full Press Release Details

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 1:30 p.m. ET.
A link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals

Frequently Asked Questions

When will BioCryst present at the J.P. Morgan Healthcare Conference?

BioCryst will present on January 12, 2026, at 1:30 p.m. ET.

Where can I find the live audio webcast of the presentation?

The live audio webcast can be accessed on BioCryst’s website.

What is the Nasdaq symbol for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals is listed under the Nasdaq symbol BCRX.

What type of company is BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals is a biopharmaceutical company.

ShareAdd on Google
Tags: BCRX Viatris Investor Conferences Healthcare BioCryst Pharmaceuticals J.P. Morgan Healthcare Conference healthcare pharmaceuticals
Last updated: Jan 6, 2026

Biotech snapshot

Cash runway
$353M liquidity · $0M/mo burn
Low dilution risk
Lead asset
PeramivirPhase 3
Influenza →

Catalyst track record

+23%
best trade around BCRX's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for BCRX.

See every catalyst's timing & PoA →